Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


14.01.2019

1 BMC Neurol
2 Int J Neurosci
2 Neurochem Res
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. SINGH JA, Cleveland JD
    Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.
    BMC Neurol. 2019;19:4.
    PubMed     Text format     Abstract available


    Int J Neurosci

  2. GRUNERT R, Krause A, Feig S, Meixensberger J, et al
    A technical concept of a computer game for patients with Parkinson's disease - a new form of PC based physiotherapy.
    Int J Neurosci. 2019 Jan 9:1-9. doi: 10.1080/00207454.2019.1567510.
    PubMed     Text format     Abstract available

  3. RANA AQ, Qureshi ARM, Rizvi SFH, Mohiuddin MM, et al
    Parkinson's Pain is More Aching and Interfering with Social Life in Caucasians Compared to Indians.
    Int J Neurosci. 2019 Jan 7:1-11. doi: 10.1080/00207454.2019.1566232.
    PubMed     Text format     Abstract available


    Neurochem Res

  4. GUREEV AP, Popov VN
    Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.
    Neurochem Res. 2019 Jan 7. pii: 10.1007/s11064-018-02711.
    PubMed     Text format     Abstract available

  5. PROROK T, Jana M, Patel D, Pahan K, et al
    Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptoralpha.
    Neurochem Res. 2019 Jan 5. pii: 10.1007/s11064-018-02705.
    PubMed     Text format     Abstract available


    PLoS One

  6. HAEGELEN C, Baumgarten C, Houvenaghel JF, Zhao Y, et al
    Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation.
    PLoS One. 2018;13:e0200262.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: